Revolution Medicines (RVMD) Q2 2025 Earnings Call August 06, 2025 04:30 PM ET Company ParticipantsRyan Asay - SVP & Corporate AffairsMark Goldsmith - CEO, President & ChairmanJack Anders - CFOSteve Kelsey - President - Research & DevelopmentAnthony Mancini - Chief Global Commercialization OfficerEllie Merle - ED - Biotech Equity ResearchAndrea Newkirk - Biotechnolgy Equity ResearchPoorna Kannan - Biotech Equity Research AssociateWei Lin - Chief Medical OfficerAlec Stranahan - VP - Equity ResearchConference ...